Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00756275 · ClinicalTrials.gov registry record · NA
Varenicline and Motivational Advice for Smokers With Substance Use Disorders
A NA study, sponsored by Brown University.
- Completed
- Registry status
- NA
- Development phase
- 158
- Enrollment target
NCT00756275: Completed NA study, sponsored by Brown University.
NCT00756275 is a NA study that has completed, run by Brown University. The registered enrollment target is 158 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00756275, a NA study, has completed, sponsored by Brown University.
- COMPLETED
- Registry status
- NA
- Development phase
- 158 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effects of 12 weeks of varenicline as compared to nicotine replacement therapy for smoking cessation among outpatients in treatment for substance use disorders. The intervention also incorporates counseling (Brief Advice), (adapted for sobriety settings), skills training and medication management.
Primary Outcome
7 -day smoking cessation confirmed by expired alveolar CO levels of \< 10 ppm or salivary cotinine \< 16 ng/ml.
Interventions
- DRUG varenicline
- DRUG Nicotine Replacement Treatment (NRT)
- BEHAVIORAL Behavioral counseling for smoking cessation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 158 participants |
| Start Date | 2009-01 |
| Est. Completion | 2014-09 |
| Phase | NA |
What the finished NCT00756275 record still lists
NCT00756275 is an interventional study that assigns participants to a tested intervention. The registered 158 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 3 interventions - of which varenicline is the first listed.
NCT00756275 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00756275 about?
NCT00756275 is a clinical study titled "Varenicline and Motivational Advice for Smokers With Substance Use Disorders". The purpose of this study is to evaluate the effects of 12 weeks of varenicline as compared to nicotine replacement therapy for smoking cessation among outpatients in treatment for substance use disorders. The intervention also incorporates counseling (Brief Advice), (adapted for sobriety settings),...
What is the current status of trial NCT00756275?
This trial is currently completed. It is a NA study. The enrollment target is 158 participants. The study started on 2009-01. Estimated completion is 2014-09.
What interventions are being tested in trial NCT00756275?
The interventions under investigation include: varenicline (DRUG), Nicotine Replacement Treatment (NRT) (DRUG), Behavioral counseling for smoking cessation (BEHAVIORAL).
Who is sponsoring clinical trial NCT00756275?
This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00756275's enrollment target sits among peer trials
158 654th of 2000 higher than 1,345 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04486833 · 158 participants · Phase 1
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
- NCT04697966 · 158 participants · NA
Mechanisms and Predictors of Change in App-Based Mindfulness Training for Adolescents
- NCT04969835 · 158 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
- NCT05230732 · 158 participants · NA
Neuromodulation of Inflammation and Endothelial Function
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia